Pfizer Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $28.42B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $1.96B | 6.9% |
| Business Acquisitions | $1.00B | 3.5% |
| Other Investing | $1.45B | 5.1% |
| Stock Repurchases | $2.87B | 10.1% |
| Other Financing | $4.25B | 15.0% |
| Working Capital | $11.62B | 40.9% |
| Other | $5.27B | 18.6% |
| Net Cash Flow | $0 | 0.0% |